Neonatal Alloimmune Thrombocytopenia
Hematology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Qilu PharmaceuticalChina - Jinan
1 programStandard clinical treatment, including intravenous immunoglobulin and/or platelet transfusionN/A1 trial
Active Trials
NCT02934906Unknown
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Qilu PharmaceuticalStandard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
Clinical Trials (1)
NCT02934906Qilu PharmaceuticalStandard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Start: Jan 2017
N/AUnknown
Related Jobs in Hematology
Senior Manager – Strategy & Business Transformation
Johnson & Johnson
Mumbai, India
2d ago
MSL Hematología L - Sur
Johnson & Johnson
Sevilla, Spain
2d ago
Délégué Médical LLC/Myélome (H/F) - secteurToulouse
Johnson & Johnson
Issy-les-Moulineaux, France
2d ago
Sr. Director Marketing
Genetix Biotherapeutics
Somerville, Massachusetts, United States
5d ago
From $270K/yr
Commercial Strategy Lead – Innovative Gene Therapies (Haematology - BeNeLux)
Vertex Pharmaceuticals
5065 - Vertex Netherlands
5d ago
Key Account Specialist Hematology
Johnson & Johnson
Beirut, Lebanon
5d ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space